Clinical Trial Update: A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-2173 in participants with systemic lupus erythematosus; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SHR-2173

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: NOT_YET_RECRUITING